Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.
Understanding how cells use complex transcriptional programs to alter their fate in response to specific stimuli is an important question in biology. For the MCF-7 human breast cancer cell line, we applied gene expression trajectory models to identify the genes involved in driving cell fate transiti...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4682858?pdf=render |
| _version_ | 1819238020514054144 |
|---|---|
| author | Daniel Carbajo Shigeyuki Magi Masayoshi Itoh Hideya Kawaji Timo Lassmann Erik Arner Alistair R R Forrest Piero Carninci Yoshihide Hayashizaki Carsten O Daub FANTOM consortium Mariko Okada-Hatakeyama Jessica C Mar |
| author_facet | Daniel Carbajo Shigeyuki Magi Masayoshi Itoh Hideya Kawaji Timo Lassmann Erik Arner Alistair R R Forrest Piero Carninci Yoshihide Hayashizaki Carsten O Daub FANTOM consortium Mariko Okada-Hatakeyama Jessica C Mar |
| author_sort | Daniel Carbajo |
| collection | DOAJ |
| description | Understanding how cells use complex transcriptional programs to alter their fate in response to specific stimuli is an important question in biology. For the MCF-7 human breast cancer cell line, we applied gene expression trajectory models to identify the genes involved in driving cell fate transitions. We modified trajectory models to account for the scenario where cells were exposed to different stimuli, in this case epidermal growth factor and heregulin, to arrive at different cell fates, i.e. proliferation and differentiation respectively. Using genome-wide CAGE time series data collected from the FANTOM5 consortium, we identified the sets of promoters that were involved in the transition of MCF-7 cells to their specific fates versus those with expression changes that were generic to both stimuli. Of the 1,552 promoters identified, 1,091 had stimulus-specific expression while 461 promoters had generic expression profiles over the time course surveyed. Many of these stimulus-specific promoters mapped to key regulators of the ERK (extracellular signal-regulated kinases) signaling pathway such as FHL2 (four and a half LIM domains 2). We observed that in general, generic promoters peaked in their expression early on in the time course, while stimulus-specific promoters tended to show activation of their expression at a later stage. The genes that mapped to stimulus-specific promoters were enriched for pathways that control focal adhesion, p53 signaling and MAPK signaling while generic promoters were enriched for cell death, transcription and the cell cycle. We identified 162 genes that were controlled by an alternative promoter during the time course where a subset of 37 genes had separate promoters that were classified as stimulus-specific and generic. The results of our study highlighted the degree of complexity involved in regulating a cell fate transition where multiple promoters mapping to the same gene can demonstrate quite divergent expression profiles. |
| first_indexed | 2024-12-23T13:29:35Z |
| format | Article |
| id | doaj.art-fa589aa9e53b465b9730e82d38a42d2b |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-23T13:29:35Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-fa589aa9e53b465b9730e82d38a42d2b2022-12-21T17:45:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014417610.1371/journal.pone.0144176Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.Daniel CarbajoShigeyuki MagiMasayoshi ItohHideya KawajiTimo LassmannErik ArnerAlistair R R ForrestPiero CarninciYoshihide HayashizakiCarsten O DaubFANTOM consortiumMariko Okada-HatakeyamaJessica C MarUnderstanding how cells use complex transcriptional programs to alter their fate in response to specific stimuli is an important question in biology. For the MCF-7 human breast cancer cell line, we applied gene expression trajectory models to identify the genes involved in driving cell fate transitions. We modified trajectory models to account for the scenario where cells were exposed to different stimuli, in this case epidermal growth factor and heregulin, to arrive at different cell fates, i.e. proliferation and differentiation respectively. Using genome-wide CAGE time series data collected from the FANTOM5 consortium, we identified the sets of promoters that were involved in the transition of MCF-7 cells to their specific fates versus those with expression changes that were generic to both stimuli. Of the 1,552 promoters identified, 1,091 had stimulus-specific expression while 461 promoters had generic expression profiles over the time course surveyed. Many of these stimulus-specific promoters mapped to key regulators of the ERK (extracellular signal-regulated kinases) signaling pathway such as FHL2 (four and a half LIM domains 2). We observed that in general, generic promoters peaked in their expression early on in the time course, while stimulus-specific promoters tended to show activation of their expression at a later stage. The genes that mapped to stimulus-specific promoters were enriched for pathways that control focal adhesion, p53 signaling and MAPK signaling while generic promoters were enriched for cell death, transcription and the cell cycle. We identified 162 genes that were controlled by an alternative promoter during the time course where a subset of 37 genes had separate promoters that were classified as stimulus-specific and generic. The results of our study highlighted the degree of complexity involved in regulating a cell fate transition where multiple promoters mapping to the same gene can demonstrate quite divergent expression profiles.http://europepmc.org/articles/PMC4682858?pdf=render |
| spellingShingle | Daniel Carbajo Shigeyuki Magi Masayoshi Itoh Hideya Kawaji Timo Lassmann Erik Arner Alistair R R Forrest Piero Carninci Yoshihide Hayashizaki Carsten O Daub FANTOM consortium Mariko Okada-Hatakeyama Jessica C Mar Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage. PLoS ONE |
| title | Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage. |
| title_full | Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage. |
| title_fullStr | Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage. |
| title_full_unstemmed | Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage. |
| title_short | Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage. |
| title_sort | application of gene expression trajectories initiated from erbb receptor activation highlights the dynamics of divergent promoter usage |
| url | http://europepmc.org/articles/PMC4682858?pdf=render |
| work_keys_str_mv | AT danielcarbajo applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT shigeyukimagi applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT masayoshiitoh applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT hideyakawaji applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT timolassmann applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT erikarner applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT alistairrrforrest applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT pierocarninci applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT yoshihidehayashizaki applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT carstenodaub applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT fantomconsortium applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT marikookadahatakeyama applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage AT jessicacmar applicationofgeneexpressiontrajectoriesinitiatedfromerbbreceptoractivationhighlightsthedynamicsofdivergentpromoterusage |